Improving Clinical Outcomes Through Pharmacogenetics

February 8, 2018 - 12:00pm to 1:00pm
CAGPM Weekly Forum Series
Julie A. Johnson, Pharm.D.

Julie A. Johnson, Pharm.D., is Dean of the University of Florida College of Pharmacy and Distinguished Professor of Pharmacy and Medicine. She is also Director of the UF Health Personalized Medicine Program. She received her B.S. in Pharmacy from the Ohio State University and her Pharm.D. from the University of Texas at Austin and the UT Health Science Center at San Antonio. She completed a post-doctoral fellowship in cardiovascular pharmacology/ pharmacokinetics at Ohio State. She is a board certified pharmacotherapy specialist (BCPS) with added qualifications in cardiology.

Dr. Johnson's research focuses on cardiovascular pharmacogenomics and genomic medicine. She leads a hypertension pharmacogenomics research group, funded under the NIH Pharmacogenomics Research Network, and another NIH-funded group in genomic medicine implementation in the NIH IGNITE network. She is an internationally-recognized leader in cardiovascular pharmacogenomics and genomic medicine, with over 240 peer reviewed publications and > $35M in research funding as principal investigator.

Dr. Johnson has served on the Nonprescription Drugs Advisory Committee of the FDA, the XNDA Study Section at NIH, and in numerous scientific capacities with NIH's NHLBI. . She is an elected fellow of the ACCP, the AHA and the American College of Clinical Pharmacology.